|
Control
|
Tamsulosin
|
Solifenacin
|
Combined therapy
|
P-value
|
---|
Median (Range)
|
Median (Range)
|
Median (Range)
|
Median (Range)
|
---|
IPSS obstructive score
|
Pre-insertion
|
1 (0–3)
|
1 (0–2)
|
1 (0–4)
|
1 (0–3)
|
0.59
|
After 2 weeks
|
13a,b (6–19)
|
7a,c (0–11)
|
7c,d (3–12)
|
4b,d (2–8)
|
< 0.001
|
IPSS irritative score
|
Pre-insertion
|
2 (0–4)
|
2 (0–3)
|
1 (0–3)
|
2 (0–4)
|
0.45
|
After 2 weeks
|
11a,b (6–15)
|
6c,d (3–9)
|
5a,c (3–8)
|
4b,d (2–5)
|
< 0.001
|
Total IPSS score
|
Pre-insertion
|
3 (0–7)
|
3 (0–5)
|
2 (0–7)
|
3 (0–7)
|
0.836
|
After 2 weeks
|
24a,b,c (12–34)
|
13a,d (6–20)
|
12b,e (8–20)
|
8c,d,e (4–15)
|
< 0.001
|
- Similar letters (a, b, c, d, e) indicate significant difference
- IPSS International Prostate Symptom Score